Presentation details are as follows:
Title: A Randomized, Placebo-Controlled, Proof-of-Concept Trial of Ebopiprant for the Treatment of Spontaneous Preterm Labor (PROLONG)
Abstract ID: W-063
Poster Session: Clinical Perinatology
Presenter: Elizabeth Garner, M.D., M.P.H., Chief Medical Officer of ObsEva
Session Date: Wednesday, July 7, 2021
Session Time: 4:00-5:30 p.m. ET
.
Title: Pharmaceutical Industry Development in Preterm Labor Treatment: Current Landscape
Mini Symposia II: Update on Diagnostics and Therapeutics for Preterm Birth
Presenter: Elizabeth Garner, M.D., M.D.H., Chief Medical Officer of ObsEva
Session Date: Thursday, July 8, 2021
Session Time: 5:35-6:00 p.m. ET